Quantification of Esophageal Tumor Motion and Investigation of Different Image-Guided Correction Strategies.


Journal

Practical radiation oncology
ISSN: 1879-8519
Titre abrégé: Pract Radiat Oncol
Pays: United States
ID NLM: 101558279

Informations de publication

Date de publication:
Historique:
received: 21 08 2019
revised: 12 11 2019
accepted: 20 11 2019
pubmed: 2 12 2019
medline: 21 10 2020
entrez: 2 12 2019
Statut: ppublish

Résumé

To accurately quantify esophageal tumor position variability and to optimize image guided correction strategies. Esophageal cancer patients receiving chemoradiotherapy (41.4-50.4 Gy in 23-28 fractions combined with carboplatin plus paclitaxel) were included in a prospective cohort study (NCT02139488). Gold fiducial markers were inserted into the esophageal tumors during diagnostic endoscopic ultrasound. Four-dimensional (4D) planning computed tomography (CT) and daily 4D cone beam (CB) CT scans were acquired. Each CBCT was registered to the planning CT using different regions of interest (bone; 3D), and carina, diaphragm, clinical target volume (CTV), and fiducial markers (4D) for alignment and using the fiducial markers as the true tumor position. Subsequently, a planning target volume (PTV) margin accounting for residual uncertainties, including the average respiratory motion, was calculated for each of these registrations. Fifty-six patients with tumors located in the proximal (n = 1), mid (n = 7), or distal esophagus (n = 25) or at the gastroesophageal junction (n = 23) were included. The average peak-to-peak respiratory tumor motion was 0.20, 0.92, and 0.34 cm on the planning CT in left-right (LR), cranial-caudal (CC), and anterior-posterior (AP) directions, respectively. The required PTV margin with average motion amplitude, depending on the correction strategy used for image guidance, ranged from 0.8 cm to 1.0 cm, 1.1 cm to 1.6 cm, and 0.7 cm to 0.9 cm in LR, CC, and AP direction, respectively. A registration based on the CTV resulted in the smallest PTV margins (0.8, 1.1, and 0.7 cm in LR, CC, and AP direction, respectively). For bone registration the calculated PTV margins were 1.0, 1.3, and 0.7 cm in LR, CC, and AP directions, respectively. The registration based on the diaphragm increased PTV margins. Substantial and anisotropic position variability of esophageal tumors was observed during radiation therapy, and nonuniform margins should be considered. Cranial-caudal PTV margins need to be larger than those commonly used. Target positioning during image-guided radiotherapy could be improved with a CTV registration-based correction strategy.

Identifiants

pubmed: 31786235
pii: S1879-8500(19)30361-3
doi: 10.1016/j.prro.2019.11.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-92

Informations de copyright

Copyright © 2019 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Auteurs

Francine E M Voncken (FEM)

Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: f.voncken@nki.nl.

Sareh Nakhaee (S)

Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Barbara Stam (B)

Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Lisa Wiersema (L)

Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Sophie E Vollenbrock (SE)

Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Jolanda M van Dieren (JM)

Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Monique E van Leerdam (ME)

Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Jan-Jakob Sonke (JJ)

Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Berthe M P Aleman (BMP)

Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Peter Remeijer (P)

Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH